학술논문
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
Document Type
Article
Author
Liu, Xinxue; Munro, Alasdair P S; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dejnirattisai, Wanwisa; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L.; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A.; Kwok, Jonathan; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M.; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Serafimova, Teona; Saralaya, Dinesh; Screaton, Gavin R; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Supasa, Piyada; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C.; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N
Source
In Journal of Infection June 2022 84(6):795-813
Subject
Language
ISSN
0163-4453